(OCSL) Oaktree Specialty Lending - Ratings and Ratios
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US67401P4054
Debt, Equity, Mezzanine, Senior, Junior
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 12.24% |
| Yield on Cost 5y | 17.14% |
| Yield CAGR 5y | 32.40% |
| Payout Consistency | 90.1% |
| Payout Ratio | 96.0% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 20.4% |
| Value at Risk 5%th | 36.0% |
| Relative Tail Risk | 7.59% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.41 |
| Alpha | -19.07 |
| CAGR/Max DD | -0.09 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.544 |
| Beta | 0.618 |
| Beta Downside | 0.695 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.78% |
| Mean DD | 12.50% |
| Median DD | 11.51% |
Description: OCSL Oaktree Specialty Lending January 19, 2026
Oaktree Specialty Lending Corp. (NASDAQ:OCSL) is a Business Development Company that targets middle-market companies in North America, providing bridge, first- and second-lien, mezzanine, and senior debt financing ranging from $5 million to $75 million, often with an equity co-investment component. The fund focuses on firms with enterprise values of $20 million–$150 million and EBITDA of $3 million–$50 million, and it aims to act as the lead investor across sectors such as education, business services, healthcare, manufacturing, technology, and consumer retail.
As of the latest 10-K, OCSL reported a net asset value (NAV) of roughly $1.1 billion and a weighted-average portfolio yield of 9.2%, reflecting its emphasis on higher-yielding, senior-secured credit. The fund’s performance is sensitive to the U.S. interest-rate cycle; a flattening yield curve typically tightens middle-market credit spreads, enhancing OCSL’s spread-over-LIBOR earnings. Additionally, robust M&A activity in the healthcare and technology sectors-driven by aging demographics and digital transformation-provides a steady pipeline of sponsor-led acquisition opportunities that align with OCSL’s investment mandate.
For a deeper, data-driven look at OCSL’s risk-adjusted returns and sector exposure, you may find ValueRay’s analytics platform useful.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 33.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 5.46 > 1.0 |
| NWC/Revenue: 71.01% < 20% (prev 71.78%; Δ -0.77% < -1%) |
| CFO/TA 0.06 > 3% & CFO 181.8m > Net Income 33.9m |
| Net Debt (1.41b) to EBITDA (61.2m): 22.99 < 3 |
| Current Ratio: 11.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (88.1m) vs 12m ago 7.10% < -2% |
| Gross Margin: 40.63% > 18% (prev 0.31%; Δ 4032 % > 0.5%) |
| Asset Turnover: 5.59% > 50% (prev 5.82%; Δ -0.23% > 0%) |
| Interest Coverage Ratio: 0.53 > 6 (EBITDA TTM 61.2m / Interest Expense TTM 115.8m) |
Altman Z'' (< 1.1 .. > 2.6) -1.16
| A: 0.04 (Total Current Assets 135.2m - Total Current Liabilities 12.1m) / Total Assets 3.00b |
| B: -0.29 (Retained Earnings -885.1m / Total Assets 3.00b) |
| C: 0.02 (EBIT TTM 61.2m / Avg Total Assets 3.10b) |
| D: -0.58 (Book Value of Equity -884.3m / Total Liabilities 1.54b) |
| Altman-Z'' Score: -1.16 = CCC |
ValueRay F-Score (Strict, 0-100) 46.52
| 1. Piotroski: 4.0pt |
| 2. FCF Yield: 7.12% |
| 3. FCF Margin: data missing |
| 4. Debt/Equity: 1.01 |
| 5. Debt/Ebitda: 22.99 |
| 6. ROIC - WACC: -2.49% |
| 7. RoE: 2.31% |
| 8. Revenue Trend: 7.00% |
| 9. EPS Trend: -63.05% |
What is the price of OCSL shares?
As of January 23, 2026, the stock is trading at USD 12.86 with a total of 529,845 shares traded.
Over the past week, the price has changed by -0.08%, over one month by +0.55%, over three months by -4.40% and over the past year by -7.83%.
Over the past week, the price has changed by -0.08%, over one month by +0.55%, over three months by -4.40% and over the past year by -7.83%.
Is OCSL a buy, sell or hold?
Oaktree Specialty Lending has received a consensus analysts rating of 3.33.
Therefor, it is recommend to hold OCSL.
- Strong Buy: 1
- Buy: 0
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the OCSL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.7 | 6.6% |
| Analysts Target Price | 13.7 | 6.6% |
| ValueRay Target Price | 14.4 | 11.8% |
OCSL Fundamental Data Overview January 17, 2026
P/E Trailing = 33.3333
P/E Forward = 8.6356
P/S = 3.6146
P/B = 0.7734
P/EG = 0.9343
Revenue TTM = 173.4m USD
EBIT TTM = 61.2m USD
EBITDA TTM = 61.2m USD
Long Term Debt = 1.39b USD (estimated: total debt 1.49b - short term 96.8m)
Short Term Debt = 96.8m USD (from shortTermDebt, last quarter)
Debt = 1.49b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.41b USD (from netDebt column, last quarter)
Enterprise Value = 2.55b USD (1.15b + Debt 1.49b - CCE 79.6m)
Interest Coverage Ratio = 0.53 (Ebit TTM 61.2m / Interest Expense TTM 115.8m)
EV/FCF = 14.04x (Enterprise Value 2.55b / FCF TTM 181.8m)
FCF Yield = 7.12% (FCF TTM 181.8m / Enterprise Value 2.55b)
FCF Margin = 104.9% (FCF TTM 181.8m / Revenue TTM 173.4m)
Net Margin = 19.56% (Net Income TTM 33.9m / Revenue TTM 173.4m)
Gross Margin = 40.63% ((Revenue TTM 173.4m - Cost of Revenue TTM 102.9m) / Revenue TTM)
Gross Margin QoQ = 84.43% (prev 53.95%)
Tobins Q-Ratio = 0.85 (Enterprise Value 2.55b / Total Assets 3.00b)
Interest Expense / Debt = 1.75% (Interest Expense 26.0m / Debt 1.49b)
Taxrate = 1.06% (264.0k / 24.8m)
NOPAT = 60.6m (EBIT 61.2m * (1 - 1.06%))
Current Ratio = 11.20 (Total Current Assets 135.2m / Total Current Liabilities 12.1m)
Debt / Equity = 1.01 (Debt 1.49b / totalStockholderEquity, last quarter 1.47b)
Debt / EBITDA = 22.99 (Net Debt 1.41b / EBITDA 61.2m)
Debt / FCF = 7.74 (Net Debt 1.41b / FCF TTM 181.8m)
Total Stockholder Equity = 1.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.09% (Net Income 33.9m / Total Assets 3.00b)
RoE = 2.31% (Net Income TTM 33.9m / Total Stockholder Equity 1.47b)
RoCE = 2.14% (EBIT 61.2m / Capital Employed (Equity 1.47b + L.T.Debt 1.39b))
RoIC = 2.05% (NOPAT 60.6m / Invested Capital 2.96b)
WACC = 4.54% (E(1.15b)/V(2.63b) * Re(8.19%) + D(1.49b)/V(2.63b) * Rd(1.75%) * (1-Tc(0.01)))
Discount Rate = 8.19% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.38%
[DCF Debug] Terminal Value 82.56% ; FCFF base≈116.7m ; Y1≈85.6m ; Y5≈48.7m
Fair Price DCF = 1.28 (EV 1.52b - Net Debt 1.41b = Equity 113.1m / Shares 88.1m; r=5.90% [WACC]; 5y FCF grow -31.47% → 2.90% )
[DCF Warning] FCF declining rapidly (-31.47%), DCF may be unreliable
EPS Correlation: -63.05 | EPS CAGR: -47.12% | SUE: -4.0 | # QB: 0
Revenue Correlation: 7.00 | Revenue CAGR: 14.02% | SUE: -0.20 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.38 | Chg30d=-0.005 | Revisions Net=+1 | Analysts=6
EPS current Year (2026-09-30): EPS=1.52 | Chg30d=-0.039 | Revisions Net=+0 | Growth EPS=-13.9% | Growth Revenue=-5.1%
EPS next Year (2027-09-30): EPS=1.52 | Chg30d=-0.056 | Revisions Net=-3 | Growth EPS=+0.1% | Growth Revenue=+0.2%
P/E Forward = 8.6356
P/S = 3.6146
P/B = 0.7734
P/EG = 0.9343
Revenue TTM = 173.4m USD
EBIT TTM = 61.2m USD
EBITDA TTM = 61.2m USD
Long Term Debt = 1.39b USD (estimated: total debt 1.49b - short term 96.8m)
Short Term Debt = 96.8m USD (from shortTermDebt, last quarter)
Debt = 1.49b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.41b USD (from netDebt column, last quarter)
Enterprise Value = 2.55b USD (1.15b + Debt 1.49b - CCE 79.6m)
Interest Coverage Ratio = 0.53 (Ebit TTM 61.2m / Interest Expense TTM 115.8m)
EV/FCF = 14.04x (Enterprise Value 2.55b / FCF TTM 181.8m)
FCF Yield = 7.12% (FCF TTM 181.8m / Enterprise Value 2.55b)
FCF Margin = 104.9% (FCF TTM 181.8m / Revenue TTM 173.4m)
Net Margin = 19.56% (Net Income TTM 33.9m / Revenue TTM 173.4m)
Gross Margin = 40.63% ((Revenue TTM 173.4m - Cost of Revenue TTM 102.9m) / Revenue TTM)
Gross Margin QoQ = 84.43% (prev 53.95%)
Tobins Q-Ratio = 0.85 (Enterprise Value 2.55b / Total Assets 3.00b)
Interest Expense / Debt = 1.75% (Interest Expense 26.0m / Debt 1.49b)
Taxrate = 1.06% (264.0k / 24.8m)
NOPAT = 60.6m (EBIT 61.2m * (1 - 1.06%))
Current Ratio = 11.20 (Total Current Assets 135.2m / Total Current Liabilities 12.1m)
Debt / Equity = 1.01 (Debt 1.49b / totalStockholderEquity, last quarter 1.47b)
Debt / EBITDA = 22.99 (Net Debt 1.41b / EBITDA 61.2m)
Debt / FCF = 7.74 (Net Debt 1.41b / FCF TTM 181.8m)
Total Stockholder Equity = 1.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.09% (Net Income 33.9m / Total Assets 3.00b)
RoE = 2.31% (Net Income TTM 33.9m / Total Stockholder Equity 1.47b)
RoCE = 2.14% (EBIT 61.2m / Capital Employed (Equity 1.47b + L.T.Debt 1.39b))
RoIC = 2.05% (NOPAT 60.6m / Invested Capital 2.96b)
WACC = 4.54% (E(1.15b)/V(2.63b) * Re(8.19%) + D(1.49b)/V(2.63b) * Rd(1.75%) * (1-Tc(0.01)))
Discount Rate = 8.19% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.38%
[DCF Debug] Terminal Value 82.56% ; FCFF base≈116.7m ; Y1≈85.6m ; Y5≈48.7m
Fair Price DCF = 1.28 (EV 1.52b - Net Debt 1.41b = Equity 113.1m / Shares 88.1m; r=5.90% [WACC]; 5y FCF grow -31.47% → 2.90% )
[DCF Warning] FCF declining rapidly (-31.47%), DCF may be unreliable
EPS Correlation: -63.05 | EPS CAGR: -47.12% | SUE: -4.0 | # QB: 0
Revenue Correlation: 7.00 | Revenue CAGR: 14.02% | SUE: -0.20 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.38 | Chg30d=-0.005 | Revisions Net=+1 | Analysts=6
EPS current Year (2026-09-30): EPS=1.52 | Chg30d=-0.039 | Revisions Net=+0 | Growth EPS=-13.9% | Growth Revenue=-5.1%
EPS next Year (2027-09-30): EPS=1.52 | Chg30d=-0.056 | Revisions Net=-3 | Growth EPS=+0.1% | Growth Revenue=+0.2%
Additional Sources for OCSL Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle